Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam
· Delayed Price · Currency is VND 56,400
-600 (-1.05%)
At close: Apr 14, 2025
HNX:DP3 Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 121,172 | 125,263 | 108,824 | 94,305 | 114,061 | Upgrade
|
| Depreciation & Amortization | 12,861 | 13,980 | - | - | - | Upgrade
|
| Other Amortization | 80 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -15,492 | -21,684 | - | - | - | Upgrade
|
| Other Operating Activities | -1,041 | 4,079 | -9,609 | -67,997 | 8,301 | Upgrade
|
| Change in Accounts Receivable | -24,076 | 13,163 | - | - | - | Upgrade
|
| Change in Inventory | 8,406 | 17,504 | - | - | - | Upgrade
|
| Change in Accounts Payable | -10,859 | -414.91 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 866.97 | 1,211 | - | - | - | Upgrade
|
| Operating Cash Flow | 91,917 | 153,102 | 99,215 | 26,308 | 122,361 | Upgrade
|
| Operating Cash Flow Growth | -39.96% | 54.31% | 277.13% | -78.50% | 312.20% | Upgrade
|
| Capital Expenditures | -1,465 | -6,403 | -15,089 | -446.26 | -68,243 | Upgrade
|
| Sale of Property, Plant & Equipment | 269.41 | 1,824 | - | - | - | Upgrade
|
| Other Investing Activities | 16,852 | 17,521 | 8,814 | 6,324 | 10,555 | Upgrade
|
| Investing Cash Flow | -11,330 | -102,680 | -54,654 | 25,878 | -72,688 | Upgrade
|
| Short-Term Debt Issued | - | - | 15,414 | 10,210 | 64,043 | Upgrade
|
| Long-Term Debt Issued | 10,100 | 15,110 | - | - | - | Upgrade
|
| Total Debt Issued | 10,100 | 15,110 | 15,414 | 10,210 | 64,043 | Upgrade
|
| Short-Term Debt Repaid | - | - | -12,222 | -12,060 | -67,124 | Upgrade
|
| Long-Term Debt Repaid | -17,875 | -12,565 | -1,490 | - | - | Upgrade
|
| Total Debt Repaid | -17,875 | -12,565 | -13,712 | -12,060 | -67,124 | Upgrade
|
| Net Debt Issued (Repaid) | -7,775 | 2,545 | 1,702 | -1,850 | -3,081 | Upgrade
|
| Common Dividends Paid | -64,481 | -68,698 | -49,885 | -66,529 | -60,180 | Upgrade
|
| Financing Cash Flow | -72,256 | -66,153 | -48,183 | -68,379 | -63,260 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.27 | 0.72 | 25.84 | 2.48 | -3.51 | Upgrade
|
| Net Cash Flow | 8,331 | -15,731 | -3,596 | -16,191 | -13,590 | Upgrade
|
| Free Cash Flow | 90,452 | 146,699 | 84,126 | 25,862 | 54,119 | Upgrade
|
| Free Cash Flow Growth | -38.34% | 74.38% | 225.29% | -52.21% | 82.58% | Upgrade
|
| Free Cash Flow Margin | 21.67% | 35.80% | 17.34% | 6.79% | 13.68% | Upgrade
|
| Free Cash Flow Per Share | 4207.10 | 6823.21 | 3717.11 | 1202.91 | 2517.18 | Upgrade
|
| Cash Interest Paid | 188.5 | 1,567 | 2,868 | 1,207 | 1,976 | Upgrade
|
| Cash Income Tax Paid | 31,740 | 27,665 | 24,159 | 29,399 | 25,854 | Upgrade
|
| Levered Free Cash Flow | 77,061 | 127,650 | 60,230 | 55,727 | 33,431 | Upgrade
|
| Unlevered Free Cash Flow | 77,162 | 128,646 | 64,277 | 56,008 | 34,662 | Upgrade
|
| Change in Net Working Capital | 19,740 | -35,517 | 521.53 | 13,632 | -19,572 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.